Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Conditions
Interventions
Rapastinel
Placebo
Locations
66
United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
University of Arizona Department of Psychiatry
Tucson, Arizona, United States
Woodland International Research Group
Little Rock, Arkansas, United States
Woodland Research Northwest
Rogers, Arkansas, United States
California Pharmaceutical Research Institute, Inc
Anaheim, California, United States
ProScience Research Group
Culver City, California, United States
Start Date
November 1, 2016
Primary Completion Date
December 12, 2018
Completion Date
December 18, 2018
Last Updated
December 27, 2019
NCT05415397
NCT07059234
NCT06396312
NCT06136546
NCT06398496
NCT06417619
Lead Sponsor
Naurex, Inc, an affiliate of Allergan plc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions